FDA DTC Ad Study: Firms Win Small Concession; Viewings Will Be Less Dense
This article was originally published in The Pink Sheet Daily
AbbVie, Valeant and Lilly had critiqued proposed study to assess impact of repeated exposure to direct-to-consumer drug ads on perception of risks and benefits.
You may also be interested in...
Flurry of new studies brings tally of FDA research projects on Rx drug promotion to 43; the 14 in progress and 7 pending peer review or recently published have a total cost of $15.5m.
The agency has 11 research projects under way, including a $2 million study of online Rx drug promotion; pharma spending on direct-to-consumer advertising declined in 2012 with biggest spends on Cymbalta and Cialis ads.
Companies are racing to co-develop coronavirus treatments before finalizing deal teams. These team-ups raise questions about what happens after the pandemic subsides.